10-Q · 2026-11-12
Sutro Biopharma, Inc. releases its Q3 financial results, showcasing advancements in collaborations and strategic focus in the biological products sector.
| Name | SUTRO BIOPHARMA, INC. |
|---|---|
| CIK | 0001382101 |
| Tickers | STRO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 452441988 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 650-392-8412 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Sutro Biopharma, Inc. releases its Q3 financial results, showcasing advancements in collaborations and strategic focus in the biological products sector.
Sutro Biopharma, Inc. announces its Q3 2026 financial results, reflecting ongoing developments in the biological products sector.
628 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-463816 | 005-90656 | 261562695 | 34 | 10892 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458680 | 001-38662 | 261547963 | 34 | 13029590 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458641 | 001-38662 | 261547814 | 34 | 351169 | 1 | 1 |
| 2026-11-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-124373 | 005-90656 | 261535117 | 34 | 24682 | |||
| 2026-09-22 | 4 | xslF345X06/form4-09222026_080918.xml | 0001992979-26-000004 | 9487 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352649 | 005-90656 | 261283763 | 34 | 10989 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005498 | 005-90656 | 261281585 | 34 | 12317 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-345748 | 001-38662 | 261265330 | 34 | 12754326 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-345733 | 001-38662 | 261265305 | 34 | 16017113 | 1 | 1 |
| 2026-07-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003158 | 005-90656 | 261221142 | 34 | 10900 | |||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080649.xml | 0001587487-26-000002 | 5804 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080650.xml | 0001294939-26-000002 | 5803 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080620.xml | 0001217412-26-000002 | 5818 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080653.xml | 0001536193-26-000002 | 5851 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080605.xml | 0001554591-26-000002 | 5839 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080631.xml | 0001891841-26-000002 | 5842 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080646.xml | 0001601264-26-000006 | 5830 | ||||||
| 2026-06-09 | 4 | xslF345X06/form4-06092026_080655.xml | 0001236537-26-000002 | 5783 | ||||||
| 2026-06-08 | 8-K | 8-K | 5.07 | 0001193125-26-261658 | 001-38662 | 261072496 | 34 | 145962 | 1 | 1 |
| 2026-06-02 | 4 | xslF345X06/form4-06022026_080600.xml | 0001761333-26-000005 | 7865 | ||||||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001699737-26-000010 | 005-90656 | 26988892 | 34 | 18275 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001907884-26-000008 | 005-90656 | 26986633 | 34 | 9500 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-224170 | 001-38662 | 26979589 | 34 | 10807254 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-224065 | 001-38662 | 26979119 | 34 | 346351 | 1 | 1 |
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000314 | 005-90656 | 26979039 | 34 | 9267 | |||
| 2026-05-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002548 | 005-90656 | 26932601 | 34 | 17868 | |||
| 2026-04-22 | ARS | ARS | 0001140361-26-016150 | 001-38662 | 26884579 | 34 | 5888099 | |||
| 2026-04-22 | DEFA14A | DEFA14A | 0001193125-26-170441 | 001-38662 | 26883970 | 34 | 7302707 | 1 | 1 | |
| 2026-04-22 | DEF 14A | DEF 14A | 0001193125-26-170354 | 001-38662 | 26883732 | 34 | 14603911 | 1 | 1 | |
| 2026-04-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-046182 | 005-90656 | 26880779 | 34 | 15587 | |||
| 2026-04-21 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-166842 | 005-90656 | 26879723 | 34 | 652813 | |||
| 2026-04-01 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001050 | 333-294541 | 26830456 | 33 | 1815 | ||
| 2026-04-01 | 424B3 | 424B3 | 0001193125-26-138220 | 333-294541 | 26829469 | 33 | 337009 | |||
| 2026-03-30 | CORRESP | filename1.htm | 0001193125-26-131936 | 8311 | ||||||
| 2026-03-27 | UPLOAD | filename1.pdf | 0000000000-26-003141 | 333-294541 | 40088 | |||||
| 2026-03-23 | S-3 | S-3 | 0001193125-26-120004 | 333-294541 | 26783340 | 33 | 1120160 | 1 | 1 | |
| 2026-03-23 | S-8 | S-8 | 0001193125-26-119971 | 333-294536 | 26783195 | 33 | 360539 | 1 | 1 | |
| 2026-03-23 | 10-K | 10-K | 0001193125-26-119873 | 001-38662 | 26782976 | 34 | 18333819 | 1 | 1 | |
| 2026-03-23 | 8-K | 8-K | 1.02,2.02,9.01 | 0001193125-26-119844 | 001-38662 | 26782714 | 34 | 346948 | 1 | 1 |
| 2026-03-06 | 4 | xslF345X05/form4-03062026_090355.xml | 0002063633-26-000003 | 8954 | ||||||
| 2026-03-06 | 4 | xslF345X05/form4-03062026_090306.xml | 0001872398-26-000003 | 8962 | ||||||
| 2026-03-03 | 4 | xslF345X05/form4-03032026_110346.xml | 0002063633-26-000002 | 23232 | ||||||
| 2026-03-03 | 4 | xslF345X05/form4-03032026_110346.xml | 0001992979-26-000002 | 19485 | ||||||
| 2026-03-03 | 4 | xslF345X05/form4-03032026_110348.xml | 0001761333-26-000002 | 8551 | ||||||
| 2026-03-03 | 4 | xslF345X05/form4-03032026_110347.xml | 0001872398-26-000002 | 22719 | ||||||
| 2026-02-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-26-000502 | 005-90656 | 26651035 | 34 | 38395 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-26-000954 | 005-90656 | 26634103 | 34 | 16291 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-26-000953 | 005-90656 | 26634085 | 34 | 16229 | |||
| 2026-02-10 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-26-044934 | 001-38662 | 26617256 | 34 | 12853060 | 1 | 1 |
| 2026-02-10 | 424B5 | 424B5 | 0001193125-26-044923 | 333-275525 | 26617183 | 33 | 511127 | |||
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-26-000098 | 005-90656 | 26579985 | 34 | 15044 | |||
| 2026-01-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000550 | 001-38662 | 26543061 | 33 | 6523 | |||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_101249.xml | 0001587487-25-000004 | 12468 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_101202.xml | 0001294939-25-000004 | 12460 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_101218.xml | 0001217412-25-000003 | 12530 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_101213.xml | 0001236537-25-000008 | 12437 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_101215.xml | 0001536193-25-000004 | 12507 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091244.xml | 0001554591-25-000004 | 12491 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091243.xml | 0001891841-25-000005 | 12494 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091245.xml | 0001601264-25-000005 | 12484 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091213.xml | 0002063633-25-000006 | 12478 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091224.xml | 0001992979-25-000006 | 12734 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091238.xml | 0001761333-25-000008 | 12806 | ||||||
| 2025-12-17 | 8-K | 8-K | 8.01 | 0001193125-25-322859 | 001-38662 | 251579837 | 34 | 131843 | 1 | 1 |
| 2025-12-16 | 4 | xslF345X05/form4-12172025_011222.xml | 0001872398-25-000005 | 16852 | ||||||
| 2025-12-03 | 8-K | 8-K | 3.03,5.03,8.01,9.01 | 0001193125-25-306786 | 001-38662 | 251546844 | 34 | 207657 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-270036 | 001-38662 | 251459396 | 34 | 13112947 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-269833 | 001-38662 | 251459209 | 34 | 307924 | 1 | 1 |
| 2025-10-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001999371-25-015943 | 005-90656 | 251413088 | 34 | 9355 | |||
| 2025-10-16 | 4 | xslF345X05/form4-10162025_121041.xml | 0001992979-25-000004 | 5259 | ||||||
| 2025-10-16 | 4 | xslF345X05/form4-10162025_121041.xml | 0001761333-25-000005 | 5236 | ||||||
| 2025-10-16 | 4 | xslF345X05/form4-10162025_121000.xml | 0001872398-25-000004 | 4695 | ||||||
| 2025-10-16 | 4 | xslF345X05/form4-10162025_121046.xml | 0001236537-25-000006 | 4622 | ||||||
| 2025-10-16 | 4 | xslF345X05/form4-10162025_121018.xml | 0002063633-25-000004 | 5014 | ||||||
| 2025-09-29 | 8-K | 8-K | 2.05,9.01 | 0001193125-25-223434 | 001-38662 | 251357270 | 34 | 177592 | 1 | 1 |
| 2025-09-22 | 4 | xslF345X05/form4-09222025_090937.xml | 0001992979-25-000003 | 9028 | ||||||
| 2025-09-12 | 3/A | xslF345X02/form3a-09122025_080949.xml | 0001415889-25-024376 | 4545 | ||||||
| 2025-08-26 | 4 | xslF345X05/form4-08272025_010822.xml | 0001415889-25-023084 | 9013 | ||||||
| 2025-08-26 | 4 | xslF345X05/form4-08272025_010839.xml | 0001415889-25-023083 | 9001 | ||||||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022031 | 005-90656 | 251221566 | 34 | 12725 | |||
| 2025-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-004735 | 005-90656 | 251213797 | 34 | 17524 | |||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105219 | 001-38662 | 251195158 | 34 | 13042383 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105159 | 001-38662 | 251194934 | 34 | 333753 | 1 | 1 |
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-001053 | 005-90656 | 251160688 | 34 | 6297 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002548 | 005-90656 | 251128473 | 34 | 10863 | |||
| 2025-06-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-064161 | 005-90656 | 251092624 | 34 | 15238 | |||
| 2025-06-25 | 8-K | 8-K | 3.01 | 0000950170-25-089978 | 001-38662 | 251073985 | 34 | 166694 | 1 | 1 |
| 2025-06-10 | 8-K | 8-K | 5.07 | 0001193125-25-138481 | 001-38662 | 251037518 | 34 | 147259 | 1 | 1 |
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080610.xml | 0001415889-25-016471 | 5630 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080628.xml | 0001415889-25-016470 | 5629 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080644.xml | 0001415889-25-016469 | 5644 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080602.xml | 0001415889-25-016468 | 5609 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080614.xml | 0001415889-25-016467 | 5664 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080630.xml | 0001415889-25-016466 | 5665 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080632.xml | 0001415889-25-016464 | 5666 | ||||||
| 2025-06-10 | 4 | xslF345X05/form4-06102025_080619.xml | 0001415889-25-016463 | 5664 | ||||||
| 2025-06-02 | 4 | xslF345X05/form4-06022025_080648.xml | 0001415889-25-015142 | 8077 | ||||||
| 2025-06-02 | 3 | xslF345X02/form3-06022025_080656.xml | 0001415889-25-015141 | 10330 | ||||||
| 2025-06-02 | 8-K | 8-K | 5.02 | 0001193125-25-133268 | 001-38662 | 251014789 | 34 | 140659 | 1 | 1 |
| 2025-05-30 | S-8 | S-8 | 0000950170-25-079768 | 333-287688 | 251011469 | 33 | 755246 | 1 | 1 | |
| 2025-05-19 | 4 | xslF345X05/form4-05192025_080539.xml | 0001415889-25-013618 | 16937 | ||||||
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001085146-25-003248 | 005-90656 | 25950253 | 34 | 9300 | |||
| 2025-05-08 | 10-Q | 10-Q | 0000950170-25-067072 | 001-38662 | 25926773 | 34 | 11105741 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-067061 | 001-38662 | 25926715 | 34 | 398276 | 1 | 1 |
| 2025-05-05 | 4 | xslF345X05/form4-05052025_090517.xml | 0001415889-25-011998 | 21565 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05052025_090515.xml | 0001415889-25-011997 | 8972 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05052025_090507.xml | 0001415889-25-011996 | 13366 | ||||||
| 2025-04-25 | ARS | ARS | 0001140361-25-015788 | 001-38662 | 25874678 | 34 | 2830726 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0000950170-25-058787 | 001-38662 | 25874670 | 34 | 5309077 | 1 | 1 | |
| 2025-04-25 | DEF 14A | DEF 14A | 0000950170-25-058774 | 001-38662 | 25874584 | 34 | 13665920 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000809 | 005-90656 | 25844743 | 34 | 10905 | |||
| 2025-04-15 | 4 | xslF345X05/form4-04152025_080443.xml | 0001415889-25-010683 | 8980 | ||||||
| 2025-04-14 | PRE 14A | PRE 14A | 0000950170-25-053739 | 001-38662 | 25836431 | 34 | 13664971 | 1 | 1 | |
| 2025-04-14 | 8-K | 8-K | 5.02 | 0000950170-25-053733 | 001-38662 | 25836369 | 34 | 152701 | 1 | 1 |
| 2025-04-08 | 4 | xslF345X05/form4-04082025_080404.xml | 0001415889-25-010385 | 8108 | ||||||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_080457.xml | 0001415889-25-010384 | 8133 | ||||||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_080432.xml | 0001415889-25-010383 | 8125 | ||||||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_080441.xml | 0001415889-25-010382 | 8132 | ||||||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_080422.xml | 0001415889-25-010381 | 8083 | ||||||
| 2025-04-08 | 3 | xslF345X02/form3-04082025_080433.xml | 0001415889-25-010380 | 24446 | ||||||
| 2025-04-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-010207 | 005-90656 | 25815384 | 34 | 18777 | |||
| 2025-03-13 | 10-K | 10-K | 0000950170-25-038884 | 001-38662 | 25736870 | 34 | 17691067 | 1 | 1 | |
| 2025-03-13 | 8-K | 8-K | 2.02,2.05,5.02,9.01 | 0000950170-25-038879 | 001-38662 | 25736814 | 34 | 474752 | 1 | 1 |
| 2025-03-07 | 4 | xslF345X05/form4-03072025_090322.xml | 0001415889-25-007405 | 9843 | ||||||
| 2025-03-07 | 4 | xslF345X05/form4-03072025_090312.xml | 0001415889-25-007398 | 9965 | ||||||
| 2025-03-07 | 4 | xslF345X05/form4-03072025_090300.xml | 0001415889-25-007393 | 8778 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_090345.xml | 0001415889-25-007185 | 8781 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_090328.xml | 0001415889-25-007184 | 9968 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_090325.xml | 0001415889-25-007183 | 9848 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_090350.xml | 0001415889-25-007182 | 8958 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110314.xml | 0001415889-25-006714 | 12548 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110302.xml | 0001415889-25-006712 | 12723 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110358.xml | 0001415889-25-006709 | 14122 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110331.xml | 0001415889-25-006696 | 8993 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110305.xml | 0001415889-25-006690 | 13613 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_100339.xml | 0001415889-25-006656 | 12751 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_100306.xml | 0001415889-25-006655 | 14294 | ||||||
| 2025-02-27 | S-8 | S-8 | 0000950170-25-029118 | 333-285346 | 25679584 | 33 | 371510 | 1 | 1 | |
| 2024-12-10 | 8-K | 8-K | 8.01 | 0000950170-24-134765 | 001-38662 | 241537152 | 34 | 158581 | 1 | 1 |
| 2024-12-03 | 4 | xslF345X05/form4-12032024_091242.xml | 0001415889-24-028066 | 8966 | ||||||
| 2024-11-14 | SC 13G/A | SUTRO BIOPHARMA, INC. | 0000902664-24-006662 | 005-90656 | 241465327 | 34 | 76160 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-002724 | 005-90656 | 241463155 | 34 | 266576 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-126407 | 001-38662 | 241454991 | 34 | 10686360 | 1 | 1 | |
| 2024-11-13 | SC 13G/A | SC 13G/A | 0001104659-24-117750 | 005-90656 | 241454871 | 34 | 73210 | |||
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-126382 | 001-38662 | 241454826 | 34 | 372121 | 1 | 1 |
| 2024-11-12 | SC 13G/A | UnitedStates_13G__SutroBioph.txt | 0000932471-24-001222 | 005-90656 | 241450200 | 34 | 6623 | |||
| 2024-11-12 | SC 13G/A | p24-3036sc13ga.htm | 0000902664-24-006411 | 005-90656 | 241444238 | 34 | 72981 | |||
| 2024-11-04 | SC 13G/A | STRO_SC13GA1_2024.htm | 0001319244-24-000056 | 005-90656 | 241423530 | 34 | 95764 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__SutroBioph.txt | 0000932471-24-000748 | 005-90656 | 241422561 | 34 | 5677 | |||
| 2024-09-20 | 4 | xslF345X05/form4-09202024_080944.xml | 0001415889-24-023745 | 9039 | ||||||
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-096336 | 001-38662 | 241202202 | 34 | 10629272 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-096313 | 001-38662 | 241202115 | 34 | 366599 | 1 | 1 |
| 2024-08-13 | 4 | xslF345X05/form4-08132024_080852.xml | 0001415889-24-021157 | 9008 | ||||||
| 2024-08-12 | 4 | xslF345X05/form4-08122024_080817.xml | 0001415889-24-021089 | 8137 | ||||||
| 2024-08-12 | 3 | xslF345X02/form3-08122024_080821.xml | 0001415889-24-021088 | 10598 | ||||||
| 2024-08-12 | 8-K | 8-K | 5.02 | 0000950170-24-095486 | 001-38662 | 241197187 | 34 | 152379 | 1 | 1 |
| 2024-07-10 | 4 | xslF345X05/form4-07102024_080725.xml | 0001415889-24-019462 | 8128 | ||||||
| 2024-07-10 | 3 | xslF345X02/form3-07102024_080709.xml | 0001415889-24-019461 | 10750 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080603.xml | 0001415889-24-016228 | 5632 | ||||||
| 2024-06-10 | 8-K | 8-K | 5.07 | 0000950170-24-071335 | 001-38662 | 241033160 | 34 | 176642 | 1 | 1 |
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080652.xml | 0001415889-24-016227 | 5631 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080628.xml | 0001415889-24-016223 | 5646 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080611.xml | 0001415889-24-016219 | 5611 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080623.xml | 0001415889-24-016216 | 5666 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080615.xml | 0001415889-24-016211 | 5668 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080606.xml | 0001415889-24-016209 | 5656 | ||||||
| 2024-06-10 | 4 | xslF345X05/form4-06102024_080625.xml | 0001415889-24-016204 | 5666 | ||||||
| 2024-05-17 | DEFA14A | DEFA14A | 0001193125-24-141843 | 001-38662 | 24961074 | 34 | 14108 | |||
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058718 | 001-38662 | 24939657 | 34 | 10456682 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-058701 | 001-38662 | 24939549 | 34 | 363824 | 1 | 1 |
| 2024-05-03 | 4 | xslF345X05/form4-05032024_080512.xml | 0001415889-24-012170 | 8986 | ||||||
| 2024-04-26 | ARS | ARS | 0001140361-24-022513 | 001-38662 | 24884509 | 34 | 3984540 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049207 | 001-38662 | 24884354 | 34 | 2244993 | 1 | 1 | |
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049212 | 001-38662 | 24884341 | 34 | 4011858 | |||
| 2024-04-12 | 4 | xslF345X05/form4-04122024_090423.xml | 0001415889-24-010772 | 8995 | ||||||
| 2024-04-05 | SC 13G | p24-1385sc13g.htm | 0000902664-24-002770 | 005-90656 | 24826488 | 34 | 84331 | |||
| 2024-04-02 | 8-K | 8-K | 1.01,9.01 | 0000950170-24-040345 | 001-38662 | 24815468 | 34 | 702418 | 1 | 1 |
| 2024-04-02 | 424B5 | 424B5 | 0001193125-24-084879 | 333-275525 | 24815294 | 33 | 407210 | |||
| 2024-04-02 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0000950170-24-039736 | 001-38662 | 24812110 | 34 | 238142 | 1 | 1 |
| 2024-03-25 | 10-K | 10-K | 0000950170-24-035949 | 001-38662 | 24779614 | 34 | 17913546 | 1 | 1 | |
| 2024-03-25 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-035948 | 001-38662 | 24779578 | 34 | 357391 | 1 | 1 |
| 2024-03-22 | 4/A | xslF345X05/form4a-03222024_080335.xml | 0001415889-24-008954 | 5918 | ||||||
| 2024-03-22 | 4/A | xslF345X05/form4a-03222024_080326.xml | 0001415889-24-008953 | 5974 | ||||||
| 2024-03-22 | 4/A | xslF345X05/form4a-03222024_080309.xml | 0001415889-24-008952 | 5782 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03082024_120344.xml | 0001415889-24-007222 | 19101 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090338.xml | 0001415889-24-007189 | 8116 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090300.xml | 0001415889-24-007188 | 14560 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090326.xml | 0001415889-24-007184 | 8114 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090340.xml | 0001415889-24-007183 | 8087 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090326.xml | 0001415889-24-007182 | 8092 | ||||||
| 2024-03-07 | 4 | xslF345X05/form4-03072024_090345.xml | 0001415889-24-007181 | 13489 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4-03062024_090306.xml | 0001415889-24-007039 | 9847 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4-03062024_090303.xml | 0001415889-24-007030 | 9969 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4-03062024_090325.xml | 0001415889-24-007020 | 8958 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4-03062024_090307.xml | 0001415889-24-007012 | 8782 | ||||||
| 2024-03-05 | 4 | xslF345X05/form4-03052024_090304.xml | 0001415889-24-006738 | 8996 | ||||||
| 2024-03-05 | 4 | xslF345X05/form4-03052024_090358.xml | 0001415889-24-006725 | 9852 | ||||||
| 2024-03-05 | 4 | xslF345X05/form4-03052024_090313.xml | 0001415889-24-006712 | 9974 | ||||||
| 2024-03-05 | 4 | xslF345X05/form4-03052024_090320.xml | 0001415889-24-006687 | 8964 | ||||||
| 2024-03-05 | 4 | xslF345X05/form4-03052024_090359.xml | 0001415889-24-006651 | 8786 | ||||||
| 2024-03-04 | 4 | xslF345X05/form4-03042024_090339.xml | 0001415889-24-006267 | 9019 | ||||||
| 2024-02-27 | S-8 | S-8 | 0000950170-24-021231 | 333-277404 | 24687494 | 33 | 190594 | |||
| 2024-02-13 | SC 13G/A | d10963170_13g-a.htm | 0000919574-24-000959 | 005-90656 | 24623905 | 34 | 120547 | |||
| 2024-02-12 | SC 13G/A | SC 13G/A | 0001104659-24-013564 | 005-90656 | 24617237 | 34 | 73936 | |||
| 2024-02-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-030094 | 001-38662 | 24615432 | 34 | 432697 | 1 | 1 |
| 2024-02-09 | 424B5 | 424B5 | 0001193125-24-030080 | 333-275525 | 24615405 | 33 | 344481 | |||
| 2024-02-07 | SC 13G/A | SUTRO BIOPHARMA, INC. | 0000902664-24-001187 | 005-90656 | 24602219 | 34 | 94751 | |||
| 2024-01-31 | 4 | xslF345X05/form4-01312024_090125.xml | 0001415889-24-002072 | 9835 | ||||||
| 2024-01-31 | 4 | xslF345X05/form4-01312024_090157.xml | 0001415889-24-002071 | 8769 | ||||||
| 2024-01-31 | 4 | xslF345X05/form4-01312024_090153.xml | 0001415889-24-002067 | 9957 | ||||||
| 2024-01-31 | 4 | xslF345X05/form4-01312024_090124.xml | 0001415889-24-002065 | 10667 | ||||||
| 2024-01-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000502 | 001-38662 | 24574629 | 33 | 7215 | |||
| 2024-01-24 | SC 13G/A | us8693671021_012424.txt | 0001086364-24-002697 | 005-90656 | 24557789 | 34 | 13509 | |||
| 2024-01-17 | SC 13G | STRO_SC13G_2024.htm | 0001319244-24-000003 | 005-90656 | 24539106 | 34 | 95860 | |||
| 2024-01-08 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-24-002690 | 001-38662 | 24518342 | 34 | 18905005 | 1 | 1 |
| 2023-12-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-057206 | 8110 | ||||||
| 2023-11-27 | 8-K | 8-K | 1.01 | 0000950170-23-066112 | 001-38662 | 231440313 | 34 | 167002 | 1 | 1 |
| 2023-11-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-21 16:00:00 | 9999999995-23-003414 | 333-275525 | 231429873 | 33 | 1774 | ||
| 2023-11-21 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-23-065482 | 001-38662 | 231428050 | 34 | 190285 | 1 | 1 |
| 2023-11-17 | CORRESP | filename1.htm | 0001193125-23-279783 | 8421 | ||||||
| 2023-11-16 | UPLOAD | filename1.pdf | 0000000000-23-012595 | 40339 | ||||||
| 2023-11-13 | S-3 | S-3 | 0001193125-23-276208 | 333-275525 | 231400097 | 33 | 745606 | |||
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-063037 | 001-38662 | 231399402 | 34 | 13125161 | 1 | 1 | |
| 2023-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-063021 | 001-38662 | 231399295 | 34 | 438592 | 1 | 1 |
| 2023-10-10 | SC 13G | SUTRO BIOPHARMA, INC. | 0000902664-23-005066 | 005-90656 | 231318509 | 34 | 100382 | |||
| 2023-10-04 | 8-K | 8-K | 1.01 | 0000950170-23-051917 | 001-38662 | 231308410 | 34 | 166716 | 1 | 1 |
| 2023-09-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-049943 | 8153 | ||||||
| 2023-09-19 | 3 | FORM 3 SUBMISSION | 0001209191-23-049933 | 6957 | ||||||
| 2023-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-047608 | 5580 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047512 | 5224 | ||||||
| 2023-08-25 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000707 | 001-38662 | 231209016 | 33 | 8378 | |||
| 2023-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-045434 | 9117 | ||||||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041416 | 001-38662 | 231160122 | 34 | 14661738 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041404 | 001-38662 | 231160084 | 34 | 485067 | 1 | 1 |
| 2023-07-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-042244 | 9131 | ||||||
| 2023-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-040213 | 6508 | ||||||
| 2023-06-26 | 8-K | 8-K | 1.01 | 0000950170-23-029731 | 001-38662 | 231039459 | 34 | 172512 | 1 | 1 |
| 2023-06-14 | 8-K | 8-K | 1.02,5.07 | 0000950170-23-027975 | 001-38662 | 231014537 | 34 | 220730 | 1 | 1 |
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036479 | 5590 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036474 | 5554 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036473 | 5553 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036472 | 5568 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036471 | 5533 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036470 | 5588 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036467 | 5572 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036466 | 5588 | ||||||
| 2023-05-15 | 10-Q | 10-Q | 0000950170-23-021976 | 001-38662 | 23918530 | 34 | 11853295 | 1 | 1 | |
| 2023-05-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021973 | 001-38662 | 23918502 | 34 | 475865 | 1 | 1 |
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026736 | 8129 | ||||||
| 2023-05-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-026700 | 12677 | ||||||
| 2023-04-28 | ARS | ARS | 0001140361-23-021534 | 001-38662 | 23866177 | 34 | 1923954 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0000950170-23-015774 | 001-38662 | 23865972 | 34 | 1860101 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0000950170-23-015762 | 001-38662 | 23865831 | 34 | 3099417 | |||
| 2023-04-27 | 8-K | 8-K | 5.02 | 0000950170-23-015323 | 001-38662 | 23857633 | 34 | 165754 | 1 | 1 |
| 2023-04-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-024550 | 9084 | ||||||
| 2023-04-14 | 8-K | 8-K | 5.02 | 0000950170-23-012879 | 001-38662 | 23821178 | 34 | 168219 | 1 | 1 |
| 2023-04-14 | PRE 14A | PRE 14A | 0000950170-23-012876 | 001-38662 | 23821152 | 34 | 3098370 | |||
| 2023-03-30 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-010978 | 001-38662 | 23781152 | 34 | 460057 | 1 | 1 |
| 2023-03-30 | 10-K | 10-K | 0000950170-23-010976 | 001-38662 | 23781150 | 34 | 19782475 | 1 | 1 | |
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-019599 | 8144 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016818 | 17755 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016809 | 18632 | ||||||
| 2023-03-07 | 3 | FORM 3 SUBMISSION | 0001209191-23-016804 | 15728 | ||||||
| 2023-03-07 | 3 | FORM 3 SUBMISSION | 0001209191-23-016798 | 7516 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016794 | 17761 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016751 | 17751 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016747 | 18745 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016742 | 13856 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016739 | 15384 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016736 | 17557 | ||||||
| 2023-02-27 | S-8 | S-8 | 0000950170-23-004676 | 333-270055 | 23675506 | 33 | 469122 | |||
| 2023-02-24 | 8-K | 8-K | 5.03,9.01 | 0000950170-23-004373 | 001-38662 | 23667049 | 34 | 595800 | 1 | 1 |
| 2023-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-009236 | 6759 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001580642-23-000874 | 005-90656 | 23627645 | 34 | 57591 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000524 | 005-90656 | 23624973 | 34 | 277068 | |||
| 2023-02-13 | SC 13G/A | d9928770_13g-a.htm | 0000919574-23-000973 | 005-90656 | 23615627 | 34 | 108552 | |||
| 2023-02-10 | SC 13G | SC 13G | 0001104659-23-018473 | 005-90656 | 23611630 | 34 | 81962 | |||
| 2023-02-07 | SC 13G/A | us8693671021_020723.txt | 0001306550-23-008351 | 005-90656 | 23594597 | 34 | 13290 | |||
| 2023-02-01 | SC 13G/A | sutr22a11.htm | 0000038777-23-000037 | 005-90656 | 23575863 | 34 | 194933 | |||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005765 | 10112 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005762 | 10047 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005759 | 9052 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005757 | 9066 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005754 | 9163 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005751 | 8862 | ||||||
| 2023-01-23 | SC 13G/A | STRO_SC13GA_2023.htm | 0001273087-23-000051 | 005-90656 | 23544847 | 34 | 81728 | |||
| 2023-01-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-23-000528 | 001-38662 | 23518903 | 34 | 27048490 | 1 | 1 |
| 2022-12-20 | 8-K | 8-K | 1.01 | 0000950170-22-026823 | 001-38662 | 221474815 | 34 | 174115 | 1 | 1 |
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023279 | 001-38662 | 221369442 | 34 | 13907810 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023274 | 001-38662 | 221369402 | 34 | 479339 | 1 | 1 |
| 2022-10-24 | 8-K | 8-K | 5.02 | 0000950170-22-019872 | 001-38662 | 221324812 | 34 | 166922 | 1 | 1 |
| 2022-08-31 | S-8 | S-8 | 0000950170-22-017978 | 333-267194 | 221218335 | 33 | 489842 | |||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045297 | 9262 | ||||||
| 2022-08-08 | 10-Q | 10-Q | 0000950170-22-015584 | 001-38662 | 221145036 | 34 | 14598680 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-015573 | 001-38662 | 221144874 | 34 | 453792 | 1 | 1 |
| 2022-07-26 | 8-K | 8-K | 8.01 | 0000950170-22-013078 | 001-38662 | 221107131 | 34 | 173737 | 1 | 1 |
| 2022-07-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-042072 | 9064 | ||||||
| 2022-07-08 | SC 13G | STRO_SC13G.htm | 0001273087-22-000089 | 005-90656 | 221074605 | 34 | 81667 | |||
| 2022-06-28 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-22-012215 | 001-38662 | 221046161 | 34 | 3491769 | 1 | 1 |
| 2022-06-16 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-011712 | 001-38662 | 221019314 | 34 | 3226284 | 1 | 1 |
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035213 | 5523 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035212 | 5550 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035211 | 5522 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035210 | 5537 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035209 | 5502 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035208 | 5557 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035207 | 5559 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035206 | 5557 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035205 | 5541 | ||||||
| 2022-06-07 | 8-K | 8-K | 5.07 | 0000950170-22-011282 | 001-38662 | 221001807 | 34 | 213359 | 1 | 1 |
| 2022-05-19 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-058489,2022-05-19 | 9999999995-22-001527 | 333-255014 | 22945184 | 33 | 1786 | ||
| 2022-05-18 | POS EX | POS EX | 0001564590-22-020653 | 333-255014 | 22939080 | 33 | 350376 | |||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008531 | 001-38662 | 22905616 | 34 | 10840764 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008525 | 001-38662 | 22905539 | 34 | 388095 | 1 | 1 |
| 2022-04-25 | DEFA14A | DEFA14A | 0000950170-22-006032 | 001-38662 | 22847079 | 34 | 1132954 | |||
| 2022-04-25 | DEF 14A | DEF 14A | 0000950170-22-006031 | 001-38662 | 22847070 | 34 | 1911049 | |||
| 2022-04-20 | 8-K | 8-K | 1.01 | 0000950170-22-005825 | 001-38662 | 22836307 | 34 | 162455 | 1 | 1 |
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024540 | 9051 | ||||||
| 2022-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-018969 | 6991 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016865 | 8073 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016858 | 14872 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016856 | 15682 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016855 | 13888 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016854 | 13877 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016853 | 13850 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016850 | 13985 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016846 | 13684 | ||||||
| 2022-03-01 | S-8 | S-8 | 0001193125-22-058562 | 333-263113 | 22692299 | 33 | 86504 | |||
| 2022-03-01 | POS AM | POS AM | 0001193125-22-058489 | 333-255014 | 22692053 | 33 | 459708 | |||
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002316 | 001-38662 | 22690404 | 34 | 449669 | 1 | 1 |
| 2022-02-28 | 10-K | 10-K | 0000950170-22-002312 | 001-38662 | 22690246 | 34 | 19621568 | 1 | 1 | |
| 2022-02-28 | POSASR | POSASR | 0001193125-22-057928 | 333-255014 | 22689794 | 33 | 520724 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001580642-22-000833 | 005-90656 | 22627754 | 34 | 56126 | |||
| 2022-02-11 | SC 13G/A | d9172357_13g-a.htm | 0000919574-22-000912 | 005-90656 | 22622104 | 34 | 111148 | |||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-008198 | 26219 | ||||||
| 2022-02-04 | SC 13G | sutr21in.htm | 0000038777-22-000039 | 005-90656 | 22592422 | 34 | 207387 | |||
| 2022-02-03 | SC 13G/A | us8693671021_020222.txt | 0000834237-22-005489 | 005-90656 | 22585821 | 34 | 13382 | |||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006131 | 10049 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006129 | 9065 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006128 | 10853 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006127 | 9021 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006125 | 9054 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006121 | 9164 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006119 | 8864 | ||||||
| 2022-01-18 | SC 13G | THE SCHEDULE 13G | 0000921895-22-000169 | 005-90656 | 22535981 | 34 | 285212 | |||
| 2022-01-10 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-000168 | 001-38662 | 22519628 | 34 | 2905216 | 1 | 1 |
| 2022-01-05 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-000081 | 001-38662 | 22512428 | 34 | 1833862 | 1 | 1 |
| 2022-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-000329 | 8897 | ||||||
| 2021-12-27 | 8-K | 8-K | 1.01 | 0000950170-21-005353 | 001-38662 | 211518901 | 34 | 168901 | 1 | 1 |
| 2021-12-10 | SC 13G | d9080302_13g.htm | 0000919574-21-007392 | 005-90656 | 211485787 | 34 | 105911 | |||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066150 | 8093 | ||||||
| 2021-11-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-066148 | 7428 | ||||||
| 2021-11-17 | 8-K | 8-K | 5.02 | 0001564590-21-057374 | 001-38662 | 211418393 | 34 | 162797 | 1 | 1 |
| 2021-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-055917 | 001-38662 | 211394349 | 34 | 9367690 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-055843 | 001-38662 | 211393633 | 34 | 12801645 | 1 | 1 | |
| 2021-10-12 | 8-K | 8-K | 1.01 | 0001564590-21-050583 | 001-38662 | 211316847 | 34 | 162544 | 1 | 1 |
| 2021-09-30 | 8-K | 8-K_MERCKAMEND | 8.01 | 0001564590-21-049553 | 001-38662 | 211293562 | 34 | 200535 | 1 | 1 |
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057982 | 11330 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057981 | 14520 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057980 | 9028 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057978 | 9064 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057977 | 10056 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057976 | 9172 | ||||||
| 2021-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-057975 | 8871 | ||||||
| 2021-08-11 | 3 | FORM 3 SUBMISSION | 0001209191-21-050957 | 21080 | ||||||
| 2021-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-050956 | 8148 | ||||||
| 2021-08-11 | 3 | FORM 3 SUBMISSION | 0001209191-21-050947 | 7478 | ||||||
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-042330 | 001-38662 | 211154567 | 34 | 406188 | 1 | 1 |
| 2021-08-09 | 10-Q | 10-Q | 0001564590-21-042217 | 001-38662 | 211154005 | 34 | 11915451 | 1 | 1 | |
| 2021-08-09 | S-8 | S-8_INDUCEMENTPLAN | 0001564590-21-042216 | 333-258603 | 211154002 | 33 | 381175 | |||
| 2021-06-17 | 8-K | 8-K | 1.01,2.03 | 0001564590-21-033400 | 001-38662 | 211025979 | 34 | 167456 | 1 | 1 |
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038701 | 5532 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038699 | 5559 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038692 | 5531 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038688 | 5546 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038685 | 5511 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038682 | 5566 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038680 | 5546 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038677 | 5566 | ||||||
| 2021-06-04 | 8-K | 8-K | 5.07 | 0001564590-21-031670 | 001-38662 | 21994832 | 34 | 180938 | 1 | 1 |
| 2021-05-19 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-028892 | 001-38662 | 21941040 | 34 | 9390919 | 1 | 1 |
| 2021-05-07 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-025294 | 001-38662 | 21900179 | 34 | 372076 | 1 | 1 |
| 2021-05-07 | 10-Q | 10-Q | 0001564590-21-025155 | 001-38662 | 21899384 | 34 | 9924057 | 1 | 1 | |
| 2021-04-29 | DEF 14A | DEF 14A | 0001564590-21-022043 | 001-38662 | 21871765 | 34 | 1916665 | |||
| 2021-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-027600 | 8101 | ||||||
| 2021-04-15 | 8-K | 8-K | 8.01 | 0001564590-21-018899 | 001-38662 | 21827258 | 34 | 168518 | 1 | 1 |
| 2021-04-05 | SC 13G/A | SCHEDULE 13G/A | 0001140361-21-011664 | 005-90656 | 21806786 | 34 | 88070 | |||
| 2021-04-02 | S-3ASR | S-3ASR | 0001193125-21-105216 | 333-255014 | 21802677 | 33 | 978610 | |||
| 2021-03-18 | S-8 | S-8 | 0001564590-21-014197 | 333-254456 | 21755090 | 33 | 187803 | |||
| 2021-03-18 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-014003 | 001-38662 | 21753052 | 34 | 387163 | 1 | 1 |
| 2021-03-18 | 10-K | 10-K | 0001564590-21-013945 | 001-38662 | 21752269 | 34 | 16192501 | 1 | 1 | |
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018623 | 8044 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018622 | 8067 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018620 | 8090 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018619 | 8102 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018618 | 8211 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018617 | 7910 | ||||||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-024120 | 005-90656 | 21639244 | 34 | 237109 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-024074 | 005-90656 | 21638926 | 34 | 93570 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-023106 | 005-90656 | 21633030 | 34 | 78729 |
One latest value per concept from companyfacts (275 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 16.60M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 60.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 895.76M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170354 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 898.71M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170354 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 14 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170354 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 2.49M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 12.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-013945 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | AccretionExpense | Accretion Expense | USD | 42,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-15 | 0001564590-19-019236 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 7.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 27.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -77,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 953.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 20,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.16M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 734,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-013945 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 5.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 1.69M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | Assets | Assets | USD | 176.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 159.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 78,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 141.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | USD | 85.70M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-055843 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 141.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | BusinessExitCosts1 | Business Exit Costs | USD | 259,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 176,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 46.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations | Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations | USD | 19.41M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-14 | 0001564590-19-031883 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -105.91M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-14 | 0001564590-19-031883 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 47.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 47.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -11.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 3.33M | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 2.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 16.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 16.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -108.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 8.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 1.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 10.33M | 2019-03-31 | 2019 | Q3 | 10-Q | 2019-11-08 | 0001564590-19-041909 | |
| us-gaap | CumulativeEffectOnRetainedEarningsNetOfTax1 | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | USD | 10.33M | 2019-01-01 | 2019-03-31 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-036997 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 2.24M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 943,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -93,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -93,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | DebtCurrent | Debt, Current | USD | 4.06M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 3.13M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.115 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 276,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | -936,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 25.90M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-270036 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 36,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 1.34M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 24.23M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029555 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 48.80M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029555 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 2.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 274.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 71.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 2.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 87.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 51.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 6.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 272.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 2.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DeferredTaxLiabilitiesInvestments | Deferred Tax Liabilities, Investments | USD | 7.38M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 398,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 3.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -7.03 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.84 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008531 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -7.03 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.221 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.634 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | EffectiveIncomeTaxRateReconciliationFdiiPercent | EffectiveIncomeTaxRateReconciliationFdiiPercent | pure | -0.014 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 2.04M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.022 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 41.94M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 | |
| us-gaap | EquitySecuritiesFvNiRealizedGainLoss | Equity Securities, FV-NI, Realized Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | ForeignCurrencyTransactionGainLossAfterTax | ForeignCurrencyTransactionGainLossAfterTax | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | 2.50M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 |
| us-gaap | GainLossOnContractTermination | Gain (Loss) on Contract Termination | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -275,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 22.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -191.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -108.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | -14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 42.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -40.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 148,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -93,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -99,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 4.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -4.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 8.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -2.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | -931,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 49.17M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029555 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -6.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -5.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 1.33M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023279 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 475,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | InterestExpense | Interest Expense | USD | 1.62M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 1.30M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -4.35M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 100,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-063037 | |
| us-gaap | InvestmentIncomeNonoperating | Investment Income, Nonoperating | USD | 4.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | InvestmentOwnedAtFairValue | Investment Owned, at Fair Value | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 | |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 39.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | LeaseCost | Lease, Cost | USD | 7.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 10.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 8.29M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 8.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 8.29M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 8.29M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 8.29M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038884 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 8.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 2.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 625,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | Liabilities | Liabilities | USD | 309.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 176.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 54.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 4.06M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 4.06M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 13.31M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 4.13M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 4.13M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 | |
| us-gaap | LossOnContractTermination | Loss on Contract Termination | USD | 9.83M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-105219 |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 95.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 102.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -11.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -103.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -108.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -19.59M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001564590-20-023689 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -27.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 114.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -81.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 4.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 4.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 9.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 7.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 2.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 7.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 48.74M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 5.74M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 7.48M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 6.31M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 5.18M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 4.70M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.108 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -96,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -336,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.91M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058718 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 7,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 2.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 170,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 0 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-08 | 0001564590-19-041909 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 22,000 | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-15 | 0000950170-23-021976 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 180,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 184.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 763,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001564590-20-023689 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 103.13M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-224170 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 102.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 25.00M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 15.00M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 10.00M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-013945 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 84.74M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-013945 |
| us-gaap | ProceedsFromSaleOfEquitySecuritiesFvNi | ProceedsFromSaleOfEquitySecuritiesFvNi | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 84,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 228,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 2,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029555 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -108.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 38.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 7.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock | Receivable from Officers and Directors for Issuance of Capital Stock | USD | 208,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 91.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 858,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 9.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-224170 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 259,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 275,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 9.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.09B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 33.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 |
| us-gaap | Revenues | Revenues | USD | 11.30M | 2019-10-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.819 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008531 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.943 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.845 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.017 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008531 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.035 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 30,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 266,724 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 6.08 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 4,445 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 4,445 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-055843 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.10M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 210,000 | 2018-01-01 | 2018-12-31 | 2019 | Q1 | 10-Q | 2019-05-15 | 0001564590-19-019236 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 197,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -132.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.1 | 2025-12-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 262,279 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002312 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 187.24M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-013945 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 147,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 24.57M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 1,000 | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 6,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 7,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0000950170-24-035949 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 102.50M | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 102.99M | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 177.08M | 2017-12-31 | 2018 | FY | 10-K | 2019-04-01 | 0001564590-19-010253 | |
| us-gaap | UnrealizedGainLossOnDerivativesAndCommodityContracts | Unrealized Gain (Loss) on Derivatives and Commodity Contracts | USD | -7,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001564590-20-023689 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 13.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 17,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-010890 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010976 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 1.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 13.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 44.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119873 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 15.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 46.50M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008531 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 15.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458680 |